CLINICAL_TRIALS
trial_result
· 2024-02-01
Clinical Trial Update: Hydrochlorothiazide for Kidney Stone Recurrence Prevention [Phase 3]
Summary
A Phase 3 trial evaluating hydrochlorothiazide for preventing recurrence of kidney stones has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Nephrolithiasis | Phase 3 | Status: COMPLETED | Results posted: 2024-02-01